["New Modalities in Cancer Imaging and Therapy" XVth edition of the workshop organized by the network "Tumor Targeting, Imaging, Radiotherapies" of the Cancéropôle Grand-Ouest, 5-8 October 2022, France].

« New Modalities in Cancer Imaging and Therapy » XV
Alpha-immunotherapy Alpha-immunothérapie External beam radiotherapy Imagerie Imaging Molecular radiotherapy Radiothérapie externe Radiothérapie interne Theranostic Théranostic Vecteurs Vectors

Journal

Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 23 01 2023
revised: 16 05 2023
accepted: 13 08 2023
medline: 1 12 2023
pubmed: 26 10 2023
entrez: 25 10 2023
Statut: ppublish

Résumé

The fifteenth edition of the international workshop organized by the "Tumour Targeting and Radiotherapies network" of the Cancéropôle Grand-Ouest focused on the latest advances in internal and external radiotherapy from different disciplinary angles: chemistry, biology, physics, and medicine. The workshop covered several deliberately diverse topics: the role of artificial intelligence, new tools for imaging and external radiotherapy, theranostic aspects, molecules and contrast agents, vectors for innovative combined therapies, and the use of alpha particles in therapy.

Identifiants

pubmed: 37880044
pii: S0007-4551(23)00369-7
doi: 10.1016/j.bulcan.2023.08.007
pii:
doi:

Types de publication

English Abstract Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

1322-1331

Informations de copyright

Copyright © 2023 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Françoise Léost (F)

Cancéropôle Grand-Ouest, IRS-UN, 8, quai Moncousu, 44007 Nantes cedex 1, France. Electronic address: Francoise.leost@univ-nantes.fr.

Jacques Barbet (J)

GIP Arronax, 44800 Saint-Herblain, France.

Maryline Beyler (M)

Université de Brest, UMR CNRS-UBO 6521 CEMCA, 6, avenue V.-Le-Gorgeu, 29200 Brest, France.

Michel Chérel (M)

Nantes Université, Inserm, CNRS, Université d'Angers, CRCI(2)NA, Nantes, France.

Grégory Delpon (G)

Institut de cancérologie de l'Ouest, département de physique médicale, boulevard Jacques-Monod, 44800 Saint-Herblain, France; Laboratoire SUBATECH, UMR 6457 CNRS-IN2P3, IMT Atlantique, 4, rue Alfred-Kastler, 44307 Nantes cedex 3, France.

Emmanuel Garcion (E)

Université d'Angers, Inserm, CNRS, Nantes Université, CRCI(2)NA, Angers, France.

Sara Lacerda (S)

Université d'Orléans, centre de biophysique moléculaire, CNRS UPR 4301, rue Charles-Sadron, 45071 Orléans cedex 2, France.

Nicolas Lepareur (N)

Université de Rennes, Inrae, Inserm, CLCC Eugène-Marquis, institut nutrition, métabolismes et cancer (NUMECAN), UMR 1317, Rennes, France.

Latifa Rbah-Vidal (L)

Nantes Université, Inserm, CNRS, Université d'Angers, CRCI(2)NA, Nantes, France.

Loïg Vaugier (L)

Institut de cancérologie de l'Ouest, département de physique médicale, boulevard Jacques-Monod, 44800 Saint-Herblain, France; Laboratoire SUBATECH, UMR 6457 CNRS-IN2P3, IMT Atlantique, 4, rue Alfred-Kastler, 44307 Nantes cedex 3, France.

Dimitris Visvikis (D)

Inserm, LaTIM, UMR 1101, IBSAM, UBO, UBL, 22, rue Camille-Desmoulins, 29238 Brest, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH